Le Lézard
Classified in: Health, Science and technology
Subjects: TDS, FVT

BioNJ Announces Lineup for BioPartnering Conference


TRENTON, N.J., April 25, 2024 /PRNewswire/ -- BioNJ is pleased to host its 14th Annual BioPartnering Conference on Tuesday, May 14, at the Liberty Science Center in Jersey City. Sponsored by J.P. Morgan, Johnson & Johnson and Morgan Lewis and hosted by Jersey City Economic Development Corp., the Conference will bring together life sciences executives, investors, strategics, academic collaborators and business development professionals for 1-1 partnering, Industry Connections (office hours with large biopharma companies), exhibits, company pitch presentations, plenary sessions and lots of networking -- including a closing networking reception. 

The action-packed schedule is designed to create meaningful opportunities, grow the ecosystem and bolster medical innovation. Timely plenary sessions will include:

And, featuring thought leaders, such as:

In addition, attendees can schedule 10-minute appointments at the Industry Connections Desk offering one-on-one time with BD professionals from large biopharma companies, such as Ferring Pharmaceuticals, Johnson & Johnson, Merck & Co., Pfizer, Sanofi and Teva Pharmaceuticals.

"The BioPartnering Conference is the ideal chance to discover innovative companies for investment portfolios," BioNJ President and CEO Debbie Hart noted. "We have more than 90 companies from the life sciences, biotech, healthcare and digital health sectors presenting new innovations and technologies. With the One-on-One Partnering System open, attendees can begin scheduling meetings to explore collaboration opportunities."

Emerging companies that will be presenting include:

Early stage start-up pitches include:

Conference attendees will have the opportunity to meet with a wide variety of exhibitors showcasing valuable resources, products and services available to the BioNJ community, including:

"We look forward to welcoming BioNJ's preeminent 2024 BioPartnering Conference to the Liberty Science Center and introducing attendees to SciTech Scity, the 30-acre innovation campus we are now building that will focus on biomedical science, home healthcare, planet care and artificial intelligence," said Paul Hoffman, President and CEO, Liberty Science Center and SciTech Scity. 

Register and find additional information at BioNJ.org/BioPartnering. Registration is $425 for BioNJ Members and $525 for Future BioNJ Members. Last year's BioPartnering Conference brought together nearly 600 attendees from 16 states and 16 countries as well as the District of Columbia. 

Media Contact
Randi Bromberg
Sr. Vice President, Communications and Marketing
O) 609-890-3185
C) 609-955-1067
[email protected]

SOURCE BioNJ


These press releases may also interest you

at 08:05
Pushing the Boundaries of Neuroscience with GE HealthCare's SIGNA MAGNUS
GE HealthCare today unveiled SIGNA MAGNUS, an FDA 510(k) pending head-only magnetic resonance (MR) scanner designed to explore advancements in neuroscience, which have been restricted by the performance limitations of conventional whole-body MR...

at 07:00
2024 National Hospice Palliative Care Week 2024 - Palliative Care Means Living Well: Let's Talk About it!
To mark National Hospice Palliative Care Week, the Quebec Coalition for Palliative Care Access (the Coalition) is proud to celebrate the positive impact of palliative care on the well-being of people with life-limiting illness. Palliative care is...

at 06:00
Brazilian Doctor Ushering in New Era of Medical Technology for Treating Cancer and Seeks to Bring Proton Therapy to Brazil
A native born and trained Brazilian oncologist is in the forefront of a new era in the treatment of cancer patients with cutting edge proton therapy medical technology developed in Israel by P-Cure. "It is my dream to be able to bring the P-Cure...

4 mai 2024
UroGen Announces Results from ATLAS Showing Robust UGN-102 Durability of Response in New and Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer at AUA 2024
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced results from a new analysis of the ATLAS trial, which estimates using Kaplan Meier...

4 mai 2024
New Real-World Study on Retrograde Instillation of JELMYTO® for Treatment of Low-Grade Upper Tract Urothelial Cancer Reports Similar Complete Response Rate and Lower Stricture Rate Compared to OLYMPUS Pivotal Trial
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today highlights the results of a sub-analysis from a real-world patient cohort review of JELMYTO...

4 mai 2024
Celebrate Women's Heart Health Month With Gundry MD Energy Renew
Women's Heart Health Month is recognized every May and is focused on raising awareness about cardiovascular health among women. It aims to educate women about the risks, symptoms, and prevention of heart disease, which is the leading cause of death...

More news about Health...


News published on and distributed by: